{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:05:36Z","timestamp":1791993936893,"version":"4.4.0"},"reference-count":48,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,6,15]]},"DOI":"10.2169\/internalmedicine.6420-20","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T22:10:54Z","timestamp":1610662254000},"page":"1819-1826","source":"Crossref","is-referenced-by-count":12,"title":["Characteristics of Neurological Symptoms in Adult Japanese Patients with Fabry Disease"],"prefix":"10.2169","volume":"60","author":[{"given":"Jun","family":"Sawada","sequence":"first","affiliation":[{"name":"Division of Cardiology, Nephrology, Pulmonology, and Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology, Pulmonology, and Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kano","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology, Pulmonology, and Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology, Pulmonology, and Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Katayama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology, Pulmonology, and Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan"},{"name":"Department of Neurology, Asahikawa City Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Science, Kumamoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Momosaki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Science, Kumamoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Science, Kumamoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hasebe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Nephrology, Pulmonology, and Neurology, Department of Internal Medicine, Asahikawa Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Spada M, Pagliardini S, Yasuda M, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79: 31-40, 2006.","DOI":"10.1086\/504601"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wilcox WR, Oliveira JP, Hopkin RJ, et al. Women with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93: 112-128, 2008.","DOI":"10.1016\/j.ymgme.2007.09.013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous men. J Med Genet 38: 750-760, 2001.","DOI":"10.1136\/jmg.38.11.750"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34: 236-242, 2004.","DOI":"10.1111\/j.1365-2362.2004.01309.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Buechner S, Moretti M, Burlina AP, et al. Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry 79: 1249-1254, 2008.","DOI":"10.1136\/jnnp.2008.143693"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mehta A, Clarke JT, Giugliani R, et al. Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet 46: 548-552, 2009.","DOI":"10.1136\/jmg.2008.065904"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Sims K, Politei J, Banikazemi M, Lee P. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 40: 788-794, 2009.","DOI":"10.1161\/STROKEAHA.108.526293"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kolodny E, Fellgiebel A, Hilz MJ, et al. Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke 46: 302-313, 2015.","DOI":"10.1161\/STROKEAHA.114.006283"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miwa K, Yagita Y, Sakaguchi M, Kitagawa K, Sakai N, Mochizuki H. Effect of enzyme replacement therapy on basilar artery diameter in male patients with Fabry disease. Stroke 50: 1010-1012, 2019.","DOI":"10.1161\/STROKEAHA.118.024426"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yagita Y, Sakai N, Miwa K, et al. Magnetic resonance imaging findings related to stroke risk in Japanese patients with Fabry disease. Stroke 50: 2571-2573, 2019.","DOI":"10.1161\/STROKEAHA.119.025528"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kono Y, Wakabayashi T, Kobayashi M, et al. Characteristics of cerebral microbleeds in patients with Fabry disease. J Stroke Cerebrovasc Dis 25: 1320-1325, 2016.","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.02.019"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nagamatsu K, Sekijima Y, Nakamura K, et al. Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients. J Hum Genet 62: 665-670, 2017.","DOI":"10.1038\/jhg.2017.31"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38: 1-211, 2018.","DOI":"10.1177\/0333102417738202"},{"key":"14","unstructured":"14. Fazekas F, Kleinert R, Offenbacher H, et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 12: 915-921, 1991."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Fellgiebel A, Keller I, Marin D, et al. Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 72: 63-68, 2009.","DOI":"10.1212\/01.wnl.0000338566.54190.8a"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sawada T, Kido J, Yoshida S, et al. Newborn screening for Fabry disease in the western region of Japan. Mol Genet Metab Rep 22: 100562, 2020.","DOI":"10.1016\/j.ymgmr.2019.100562"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fellgiebel A, Muller MJ, Ginsberg L. CNS manifestations of Fabry's disease. Lancet Neurol 5: 791-795, 2006.","DOI":"10.1016\/S1474-4422(06)70548-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ries M, Ramaswami U, Parini R, et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 162: 767-772, 2003.","DOI":"10.1007\/s00431-003-1299-3"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Rolfs A, B\u00f6ttcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. The Lancet 366: 1794-1796, 2005.","DOI":"10.1016\/S0140-6736(05)67635-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakagawa N, Sawada J, Sakamoto N, et al. High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations. J Hum Genet 64: 891-898, 2019.","DOI":"10.1038\/s10038-019-0633-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kobayashi M, Ohashi T, Sakuma M, Ida H, Eto Y. Clinical manifestations and natural history of Japanese heterozygous women with Fabry disease. J Inherit Metab Dis 2008.","DOI":"10.1007\/s10545-007-0740-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nakagawa N, Maruyama H, Ishihara T, et al. Clinical and genetic investigation of a Japanese family with cardiac Fabry disease. Identification of a novel alpha-galactosidase A missense mutation (G195V). Int Heart J 52: 308-311, 2011.","DOI":"10.1536\/ihj.52.308"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kitani Y, Nakagawa N, Sakamoto N, et al. Unexpectedly high prevalence of coronary spastic angina in patients with Anderson-Fabry disease. Circ J 83: 481-484, 2019.","DOI":"10.1253\/circj.CJ-18-0734"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gibas AL, Klatt R, Johnson J, Clarke JT, Katz J. A survey of the pain experienced by men and women with Fabry disease. Pain Res Manag 11: 185-192, 2006.","DOI":"10.1155\/2006\/828964"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Rost NS, Cloonan L, Kanakis AS, et al. Determinants of white matter hyperintensity burden in patients with Fabry disease. Neurology 86: 1880-1886, 2016.","DOI":"10.1212\/WNL.0000000000002673"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Albano B, Dinia L, Del Sette M, Gandolfo C, Sivori G, Finocchi C. Fabry disease in patients with migraine with aura. Neurol Sci 31 (Suppl): S167-S169, 2010.","DOI":"10.1007\/s10072-010-0314-5"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 17: 15-22, 1997.","DOI":"10.1046\/j.1468-2982.1997.1701015.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44: 8-19, 2004.","DOI":"10.1111\/j.1526-4610.2004.04004.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Oie LR, Kurth T, Gulati S, Dodick DW. Migraine and risk of stroke. J Neurol Neurosurg Psychiatry 91: 593-604, 2020.","DOI":"10.1136\/jnnp-2018-318254"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. El Dib R, Gomaa H, Carvalho RP, et al. Enzyme replacement therapy for Anderson-Fabry disease. Cochrane Database Syst Rev 7: CD006663, 2016.","DOI":"10.1002\/14651858.CD006663.pub4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Grewal RP. Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry Med 23: 307-312, 1993.","DOI":"10.2190\/JKFW-3WXK-QA7N-BYLN"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Bolsover FE, Murphy E, Cipolotti L, Werring DJ, Lachmann RH. Cognitive dysfunction and depression in Fabry disease: a systematic review. J Inherit Metab Dis 37: 177-187, 2014.","DOI":"10.1007\/s10545-013-9643-x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lelieveld IM, Bottcher A, Hennermann JB, Beck M, Fellgiebel A. Eight-year follow-up of neuropsychiatric symptoms and brain structural changes in Fabry disease. PLoS One 10: e0137603, 2015.","DOI":"10.1371\/journal.pone.0137603"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Liston EH, Levine MD, Philippart M. Psychosis in Fabry disease and treatment with phenoxybenzamine. Arch Gen Psychiatry 29: 402-403, 1973.","DOI":"10.1001\/archpsyc.1973.04200030090014"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shen YC, Haw-Ming L, Lin CC, Chen CH. Psychosis in a patient with Fabry's disease and treatment with aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry 31: 779-780, 2007.","DOI":"10.1016\/j.pnpbp.2006.11.017"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gairing S, Wiest R, Metzler S, Theodoridou A, Hoff P. Fabry's disease and psychosis: causality or coincidence? Psychopathology 44: 201-204, 2011.","DOI":"10.1159\/000322794"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sawada J, Katayama T, Kano K, et al. A sporadic case of Fabry disease involving repeated fever, psychiatric symptoms, headache, and ischemic stroke in an adult Japanese woman. Intern Med 54: 3069-3074, 2015.","DOI":"10.2169\/internalmedicine.54.4719"},{"key":"38","unstructured":"38. Satoh T, Toyoshima T, Matsunaga Y, Shinoe T, Tanaka S. A case of juvenile cerebral infarction in Fabry disease, after 6 years of enzyme replacement therapy. Naika (Intern Med) 121: 357-360, 2018 (in Japanese)."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier women. J Med Genet 38: 769-775, 2001.","DOI":"10.1136\/jmg.38.11.769"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Deegan PB, Baehner AF, Barba Romero MA, et al. Natural history of Fabry disease in women in the Fabry Outcome Survey. J Med Genet 43: 347-352, 2006.","DOI":"10.1136\/jmg.2005.036327"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Burlina AP, Manara R, Caillaud C, et al. The pulvinar sign: frequency and clinical correlations in Fabry disease. J Neurol 255: 738-744, 2008.","DOI":"10.1007\/s00415-008-0786-x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Cocozza S, Russo C, Pisani A, et al. Redefining the pulvinar sign in Fabry disease. AJNR Am J Neuroradiol 38: 2264-2269, 2017.","DOI":"10.3174\/ajnr.A5420"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Burlina AP, Politei J, Cinque S, et al. The pulvinar sign in Fabry patients: the first report in female patients. J Neurol 259: 1227-1228, 2012.","DOI":"10.1007\/s00415-011-6305-5"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Reisin RC, Romero C, Marchesoni C, et al. Brain MRI findings in patients with Fabry disease. J Neurol Sci 305: 41-44, 2011.","DOI":"10.1016\/j.jns.2011.03.020"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Politei J, Schenone AB, Burlina A, et al. Vertebrobasilar dolichoectasia in Fabry disease. J Inborn Errors Metab Screen 2: 232640981454124, 2014.","DOI":"10.1177\/2326409814541246"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Lyndon D, Davagnanam I, Wilson D, et al. MRI-visible perivascular spaces as an imaging biomarker in Fabry disease. J Neurol 2020. Forthcoming.","DOI":"10.1007\/s00415-020-10209-7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Fellgiebel A, Keller I, Martus P, et al. Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients. Cerebrovasc Dis 31: 294-299, 2011.","DOI":"10.1159\/000322558"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Uceyler N, Homola GA, Guerrero Gonzalez H, et al. Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease. PLoS One 9: e87054, 2014.","DOI":"10.1371\/journal.pone.0087054"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_6420-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:33:06Z","timestamp":1624073586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_6420-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6420-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}